Gough-Palmer Antony Lawrence, Gedroyc Wladyslaw Michal Witold
MRI Department, St Mary's Hospital, Imperial Healthcare NHS trust, Praed St, London W2 1NY, United Kingdom.
World J Gastroenterol. 2008 Dec 21;14(47):7170-4. doi: 10.3748/wjg.14.7170.
A wide range of local thermal ablative therapies have been developed in the treatment of non resectable hepatocellular carcinoma (HCC) in the last decade. Laser ablation (LA) and radiofrequency ablation (RFA) are the two most widely used of these. This article provides an up to date overview of the role of laser ablation in the local treatment of HCC. General principles, technique, image guidance and patient selection are discussed. A review of published data on treatment efficacy, long term outcome and complication rates of laser ablation is included and comparison with RFA made. The role of laser ablation in combination with transcatheter arterial chemoembolisation is also discussed.
在过去十年中,已开发出多种局部热消融疗法用于治疗不可切除的肝细胞癌(HCC)。激光消融(LA)和射频消融(RFA)是其中应用最广泛的两种。本文提供了激光消融在HCC局部治疗中作用的最新概述。讨论了一般原则、技术、图像引导和患者选择。纳入了已发表的关于激光消融治疗效果、长期预后和并发症发生率的数据回顾,并与RFA进行了比较。还讨论了激光消融联合经动脉化疗栓塞的作用。